WEB DESK
Serum Institute of India (SII) CEO Adar Poonawala on Friday said the institute has applied to the Indian authorities for full market authorisation of Covishield as supplies of the Covid-19 vaccine have exceeded 125 crore doses.
Regulatory process
“Supplies of the Covishield vaccine in India have exceeded 1.25 billion doses. The Government of India now has enough data for full market authorisation, and therefore @SerumInstIndia has applied to the @CDSCO_INDIA_INF (DCGI) and @MoHFW_INDIA for this permission,” Poonawala tweeted.
He tagged the Central Drugs Standard Control Organisation (CDSCO) and Ministry of Health and Family Welfare in the tweet.